Model N Presents at the Largest, Annual Summit for Medicaid Drug Rebate Program (MDRP) Executives

Industry stakeholders convene in Chicago to discuss and plan for 2014 MDRP best practices, challenges, and opportunities.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
AMP rule, MDRP, regulatory compliance, pharma

Stay compliant, reduce revenue leakage

This an important annual event for Model N, and its customers, and provides valuable insights and guidance...

Redwood Shores, CA (PRWEB) September 10, 2013

Model N, Inc. (NYSE: MODN), a leading revenue management solutions provider to the life science and technology industries, today announced it will present at this week’s 18th annual summit on the Medicaid Drug Rebate Program (MDRP) currently running in Chicago. The summit is the foremost event of the year for all things government pricing, rebates, and regulatory in pharma with over 500 MDRP executives expected in attendance.

Model N Senior Director of Product Management, Scott Medberry, participated in yesterday’s 340B symposium for pharmaceutical manufacturers as a panelist during the “340B Hot Topics” session. The discussion covered insights on how manufacturers are getting ahead of enforcement scrutiny and avoiding HRSA audits, what manufacturers should consider doing to maintain compliance with accurate reporting of 340B ceiling prices, and lessons manufacturers can learn from HRSA’s audits of 340B covered entities.

Model N will lead a presentation this afternoon (Tues., Sept. 10 at 2:15 p.m. CDT) during the Contract Management, Business Analytics and Systems Implementation Track. In this session, “Taking Control of Bundling,” Model N Director of Global Customer Service and Support, Jesse Mendelsohn, and Model N Solution Architect, Gloria Kee, will discuss the incentive programs that are requiring the spread of bundled discounts and how to avoid noncompliance with Centers for Medicare & Medicaid Services (CMS) mandates. The presentation will also focus on areas such as managing and classifying agreements, reallocation methodology, and performing reallocations.

“The annual summit on the MDRP is the best opportunity for industry experts, pharma leaders, and government regulators to gather, discuss, and plan for the issues that impact the pharma industry in the space of government pricing,” said Ken Pulverman, vice president of marketing at Model N. “This an important annual event for Model N, and its customers, and provides valuable insights and guidance for the entire industry for the year to come.”

Model N is a gold sponsor at this year’s summit and is exhibiting at booth #15. Model N will also hold a networking dinner tonight at 7 p.m. for summit delegates at the Frontera Grill. Interested parties may RSVP at the Model N booth during the summit or email Wendy Mayerson, wmayerson(at)modeln(dot)com.

Resources:

About Model N

Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies in more than 50 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: http://www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.

Legal

Model N is a trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Press Contact

Kristin Lee Dunning
Manager, Marketing and Communications

Model N
http://www.modeln.com
650-610-4717
kdunning(at)modeln(dot)com


Contact

Follow us on: Contact's Google Plus